HIF1A and neoplasm: Altogether, these results demonstrated that the combined administration of SIM and DMXAA on the in vitro melanoma microenvironment model can target simultaneously both cell types—tumor cells and TAMs, by suppressing the expression of essential molecules (HIF-1α and ARG-1), responsible for inducing the aggressive phenotype of B16.F10 melanoma cells.